News chronological

Showing 4 items before 1160013

Filters Applied:

YOUTUBE (NewsNation) - GLP-1 Wellness Retreats: The New Luxury Weight Loss Trend? | Hot Take with Jesse Weber

Luxury wellness retreats are being designed around people who use or are considering medications such as Ozempic, Wegovy, Mounjaro and Zepbound. Think sunrise yoga, protein-focused meals, strength training and life coaching, all for $12,000 a week. On Thursday's “Hot Take with Jesse Weber,” we break down whether these retreats provide the long-term support GLP-1 users need or whether the luxury wellness industry has found its next expensive cash cow. We'll also examine why GLP-1 use has nearly quadrupled in the past two years. Then, we're joined by Jill Boyd, COO of Hilton Head Health, one of the resorts now offering a specialized GLP-1 experience, to discuss the cost, medical oversight and value.

YOUTUBE (Newsmax) - BONUS: Dr. Jen Ashton on GLP-1s and the Future of Weight-Loss Medicine | Greta Wire

Could GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound be far more than weight-loss drugs? In this special bonus episode of Greta Wire, Greta Van Susteren is joined by Dr. Jen Ashton on NEWSMAX TV’s The Record with Greta Van Susteren to discuss a new study suggesting GLP-1 drugs may be associated with reduced cancer progression in several obesity-related cancers. Dr. Ashton explains what the study found, what it does — and does not — prove, and why researchers are now looking at GLP-1 medications for possible effects on inflammation, the immune system, cancer spread, recurrence, and prevention. Greta also presses on the insurance question: if these drugs may help prevent expensive and devastating medical complications,…